title: Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia.
abstract: Serum immunoglobulin (Ig) M monoclonal protein determined by electrophoresis (sIgM-MP) and total serum IgM (sIgM) by nephelometry are widely used for response assessment in Waldenström macroglobulinemia (WM), although have not been compared for predicting changes in underlying disease burden. We, therefore, compared these serum markers with changes in bone marrow (BM) and extramedullary disease for 73 patients who were rituximab naive and treated with a rituximab-containing regimen. By linear regression analysis, reductions in sIgM-MP and sIgM showed moderate correlation with BM disease involvement (r = 0.4051 and r = 0.4490, respectively), and did not differ from one another as estimators of BM disease response (P = .3745). Neither sIgM-MP nor sIgM showed a strong correlation with BM disease response in patients with low (<1000 mg/dL) or high (>5000 mg/dL) IgM levels and extramedullary disease response. sIgM-MP and sIgM, therefore, are comparable response markers in WM. Development of newer, more accurate surrogate response markers are needed to better delineate treatment outcomes in patients with WM and with low or high IgM levels, and extramedullary disease.
authors.affiliation: Bing Center for Waldenström's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA 02215, USA.
authors.forename: Christina K
authors.initials: CK
authors.lastname: Tripsas
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Patterson
authors.forename: Sacha N
authors.initials: SN
authors.lastname: Uljon
authors.forename: Neal I
authors.initials: NI
authors.lastname: Lindeman
authors.forename: Barry
authors.initials: B
authors.lastname: Turnbull
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001797:Blood Protein Electrophoresis; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis / Q000097:blood*; D008875:Middle Aged; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000097:blood* / Q000188:drug therapy
chemical_list: D007075:Immunoglobulin M